Single-cell Analysis Market Worth $6.7 Billion By 2028 | CAGR: 15.0%

May 2021 | Report Format: Electronic (PDF)

Single-cell Analysis Market Growth & Trends

The global single-cell analysis market size is expected to reach USD 6.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.0% from 2021 to 2028. Expeditious technological advancements over the years have enabled a comprehensive analysis of transcriptome and genome in an individual cell.

Single-cell technology helps in assessing cellular heterogeneity and aids in the analysis of pathways and processes at the molecular level. This technology is evolving at a rapid pace with applications in oncology, immunology, and others. Moreover, the introduction of advanced devices that simplify transcriptomic and proteomics procedures is driving the market.

Advances in single-cell RNA sequencing (scRNAseq) allow researchers to thoroughly investigate unexplored rare cell types. The development of the microfluidics method has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field. A substantial number of microfluidic devices have been modified for cell dissociation and tissue digestion.

The increasing number of research publications is representative of the increasing investment flow in R&D in this market. As the R&D activities are the base of innovation, these investments signify a healthy growth possibility for this market. Moreover, researchers are engaged in assessing spatial heterogeneity in gene expression profiles at a single cellular level; thus, are anticipated to boost the uptake of consumables and instruments for the analysis.


key Request a free sample copy or view report summary: Single-cell Analysis Market Report


Single-cell Analysis Market Report Highlights

  • The consumables segment accounted for the largest revenue share due to the high adoption and demand of products offered under this segment

  • Given the wide availability of different forms of reagents, this segment is responsible for constant revenue generation

  • Owing to the high-end features and the technically advanced analytical options, automated instruments contributed to maximum revenue share

  • The oncology segment is majorly benefited by the advancements in single-cell analysis methods

  • To avoid risks associated with cancer therapy, single-cell analysis techniques are being heavily adopted for cancer genomics

  • There is increasing demand for prenatal diagnosis and non-invasive techniques for the detection of single-gene disorders associated with the fetus

  • This has increased the adoption of single-cell analysis for prenatal diagnosis

  • Single-cell analysis is being widely employed by various end-users, ranging from academic research institutes to biotechnology and pharmaceutical companies

  • Academic and research institutes held a significant share due to wide usage across various studies

  • North America dominated the 2020 global market owing to the increasing R&D of robust therapies and disease diagnosis

  • Asia-Pacific is projected to witness the fastest CAGR, with India and China at the forefront

  • Thermo Fisher Scientific, QIAGEN NV, Illumina Inc., Merck Millipore, BGI, Fluidigm Corporation, and Bio-Rad Laboratories are some prominent entities in this space.

  • Companies have focused on the development of new innovative products to gain a competitive advantage

Single-cell Analysis Market Segmentation

Grand View Research has segmented the global single-cell analysis market on the basis of product, application, workflow, end-use, and region:

Single Cell Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)

  • Consumables

    • Reagents

    • Assay Kits

  • Instruments

    • Microscope

    • Hemocytometers

    • Flow Cytometers

    • NGS Systems

    • PCR

    • High Content Screening Systems

    • Cell Microarrays

    • Single Live Cell Imaging

    • Automated Cell Counters

Single Cell Analysis Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Cancer

  • Immunology

  • Neurology

  • Stem cell

  • Non-invasive prenatal diagnosis

  • In-vitro fertilization

  • Others

Single Cell Analysis Workflow Outlook (Revenue, USD Million, 2017 - 2028)

  • Single-cell isolation & Library Preparation

  • Downstream Analysis

  • Data Analysis

Single Cell Analysis End-use Outlook (Revenue, USD Million, 2017 - 2028)

  • Academic & Research Laboratories

  • Biotechnology and Pharmaceutical Companies

  • Hospitals and Diagnostic Laboratories

  • Others

Single Cell Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa (MEA)

    • South Africa

    • Saudi Arabia

List of Key Players of Single-cell Analysis Market

  • Thermo Fisher Scientific

  • QIAGEN NV

  • Illumina Inc.

  • Bio-Rad Laboratories

  • 10x Genomics Inc.

  • Novogene Corporation

  • BGI

  • Fluidigm Corporation

  • Merck Millipore

  • Becton, Dickinson & Company

Pricing & Purchase Options

Service Guarantee

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Related Market Research